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Zusammenfassung 
Frühsommer-Meningoenzephalitis Virus (FSME-Virus) ist ein human-
pathogenes Virus aus der Familie Flaviviridae. Flaviviren sind einzelstrang-
RNA-Viren, die von einer Hüllmembran umgeben sind. Das Glycoprotein E an 
der Virusoberfläche ist essentiell für das Eindringen des Virus in die Wirtszelle. 
Nachdem das Virus über Endocytose von der Zelle aufgenommen wurde, 
bewirkt die Ansäuerung des Endosominneren die Fusion der viralen mit der 
endosomalen Membran. Dieser Fusion liegt eine Konformationsänderung des E 
Proteins zu Grunde, welches im nativen Zustand ein Dimer darstellt und sich bei 
saurem pH irreversibel in ein Trimer umlagert. Obwohl die atomaren Strukturen 
des C-terminal-verkürzten E Proteins bekannt sind, ist der Fusionsmechanismus 
im Detail noch nicht aufgeklärt. Biochemische Daten haben gezeigt, dass die 
„Stamm-Anker-Region“, welche in den gelösten Kristallstrukturen fehlt, 
vermutlich eine wichtige Rolle im Fusionsprozess spielt. Um die Funktion der 
„Stamm-Region“, welche das sE mit dem Transmembrananker verbindet 
genauer zu untersuchen wurden im Rahmen dieser Diplomarbeit hoch 
aufgereinigte FSME-Virus E Proteine, welche die „Stamm-Region“ beinhalten, 
rekombinant hergestellt. Die produzierten Proteine sollen später in ihrer 
trimeren, postfusionären Form kristallisiert werden, um die Rolle des 
„Stammes“ während des Fusionsprozess aufklären zu können. Für diese Zwecke 
wurde das Protein TBEsE H1/H2_dstrep, das den gesamten Stamm und TBEsE 
H1_dstrep, das nur Teile des Stammes beinhaltet, in stabil transfektierten 
Drosophila Zellen exprimiert. TBEsE H1_dstrep wurde in seiner dimeren Form 
exprimiert und wies eine Reinheit von 70-95% nach der Aufreinigung auf. Das 
aufgereinigte rekombinante Protein wurde mit saurem pH behandelt, was zur 
Umlagerung in den trimeren Zustand führte. Dieses Ergebnis ermöglicht eine 
weitere Verwendung des Proteins für Kristallisierungsstudien. 
 
 
Abstract 
Tick-borne encephalitis virus (TBEV) is an enveloped virus and an important 
human pathogen, which belongs to the family Flaviviridae. Flaviviruses, like 
other enveloped viruses, enter cells via a membrane fusion reaction driven by 
conformational transitions in the major envelope glycoprotein E. This fusion 
mechanism is triggered by the acidic pH in endosomes after virus uptake by 
receptor-mediated endocytosis. Although the dimeric pre- and trimeric 
postfusion forms of a C-terminally truncated form of E (sE) have been 
determined by atomic resolution, some steps of the fusion mechanism are still 
unexplained. The crystallized, truncated E proteins lack the so-called stem-
anchor region, which has been hypothesized to play an important role in the 
fusion process by bringing the host and viral membrane into close proximity 
through a so-called zippering action. This work focused on the preparation of 
highly purified TBEV E proteins that include the stem region for the structural 
determination of the trimeric post-fusion form. Knowledge of this structure 
should elucidate the role of the stem during membrane fusion. This work reports 
the expression of the proteins: TBEsE H1/H2_dstrep – containing the whole 
stem region - and TBEsE H1_dstrep – containing only parts of the stem, in 
stable transfected Drosophila cell lines. TBEsE H1_dstrep was purified using 
Strep tag technology. The oligomeric form, TBEsE H1_dstrep, was dimeric and 
we were able to obtain it at a high purity of 70-95%. The exposure to low pH 
allowed the transition into the trimeric post-fusion form which will be used in 
subsequent crystallization studies.  
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1. Introduction 
1.1. Flaviviruses 
The genus Flavivirus belongs to the virus family Flaviviridae and contains more 
than 70 different viruses. Most of them are transmitted to their vertebrate hosts 
by infected ticks or mosquitoes and they can cause serious, sometimes fatal 
infections in humans [1]. The most important human pathogenic flaviviruses are 
yellow fever virus (YFV), Japanese encephalitis virus (JEV), West Nile virus 
(WNV), dengue virus (DenV) and tick-borne encephalitis virus (TBEV) [2].  
 
1.1.1. Flavivirus genome 
The genome, a positive stranded RNA of about 10,800 nucleotides, consists of a 
single open reading frame (ORF) and is flanked by non-coding regions at its 5´ 
and 3´ ends (Figure 1). It codes for three structural proteins, the capsid protein 
(C), the precursor of the membrane protein (prM/M) and the envelope protein 
(E). The genomic RNA is not polyadenylated, but contains a cap structure at its 
5´end (m7G5´ppp5´A) [3]. 
 
 
Figure 1. Schematic representation of the flavivirus genome organization.  
The positive-stranded RNA genome is unsegmented. The 10.8-kDa genome has one open 
reading frame (ORF) encoding the structural proteins C, prM/M and E and a set of seven non-
structural proteins. The ORF is flanked by non-coding regions (NCRs) at both ends. The 
genomic RNA is not polyadenylated but has a CAP structure at its 5´end (modified from [4]). 
 
 
CAP
 - 2 -
1.1.2. Flavivirus lifecycle 
The assembly of flavivirus particles takes place at the endoplasmatic reticulum 
(ER) (Figure 2A), where the nucleocapsid, formed by the genome in complex with 
the capsid proteins, is packed into non-infectious immature virions (Figure 2B). 
These particles show a spiky surface that is formed by a heterodimeric complex of 
prME preproteins [5]. During the maturation process, which takes place during 
transportation through the trans-Golgi network, the particle surface undergoes a 
conformational change. This change is triggered by low pH, which enables the 
maturation cleavage of the prM protein by a host-encoded furin-like protease. This 
cleavage causes major rearrangements of the E proteins leading to mature, 
infectious particles with a smooth particle surface morphology (Figure 2B) [6, 7]. 
Once cleaved, the pr peptide remains associated with the particle until its release 
into the neutral pH of the extracellular environment [8]. The E proteins, on the 
surface of mature virions, are in a dimeric metastable conformation, and are primed 
to mediate low pH triggered membrane fusion in the endosomes after uptake by 
receptor-mediated endocytosis (Figure 2A). 
After the virus uptake, the acidic pH in the endosome induces strucutral 
alterations which lead to membrane fusion and the release of the nucleocapsid 
into the cytoplasm. There, the positive-stranded RNA genome is translated to 
initiate virus replication.  
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Figure 2. Schematic of the flavivirus lifecycle (A) and organisation of the flavivirus 
particle (B). (A) Virus entry occurs by receptor-mediated endocytosis, acidic pH in the 
endosome induces structural rearrangement in the E protein, leading to membrane fusion and 
the release of the genome into the cytoplasm. Synthesized RNA and structural proteins are 
assembled in the endoplasmic reticulum (ER) and lead to the formation of immature (prM-
containing) particles, which are transported through the exocytic pathway. Shortly before 
release through exocytosis, the particle is cleaved by the host protease furin which leads to the 
formation of mature, infectious particles (modified from [4]). (B) Schematic representation of 
a flavivirus particle in its immature (prM-containing) and mature form after proteolytic 
cleavage of prM [9]. 
 
A.                                                                                   B. 
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1.2. Structural perspectives of the flavivirus fusion machinery 
1.2.1. Structure of the E protein pre-fusion form  
The E protein of flaviviruses consists of about 500 amino acid residues and is 
glycosylated in some flaviviruses. The atomic structures of the E proteins from 
TBEV, WNV, DenV2, and DenV3 have been determined by X-ray 
crystallography using E proteins purified from infectious virus (TBEV) or 
expressed as recombinant proteins in insect cell expression systems (DenV2, 
DenV3, and WNV) [10-13]. In all cases, a soluble form of E (sE) was used, 
lacking the 100 C-terminal amino acids, including the so-called stem and the 
transmembrane helices. The basic structural feature – an antiparallel orientated 
homodimer – is common in most flavivirus E proteins crystallized so far, 
although they have less then 40% amino acid identity. Each monomer of the E 
protein is composed of three distinct domains – domain I (DI), domain II (DII) 
and domain III (DIII). DI (Figure 3, indicated in red) is the central β-barrel 
domain, which lies in parallel to the viral membrane and contains the amino 
terminus. In many of the flaviviruses, it carries the N-linked carbohydrate side 
chain (CHO). Two long disulfide stabilized loops emanate out of this central 
domain and interact to form DII (Figure 3, indicated in yellow). This elongated 
dimerization region provides inter-subunit contacts (“dimerization domain”). 
DIII (Figure 3, indicated in blue) flanks DI on the opposite side and has an Ig-
like β-barrel fold. DIII constitutes the carboxy terminus of the crystallized 
fragment [10]. The three domains are associated by flexible junctions. They are 
capable of hinge-like motions, which are important in the conversion of 
immature to mature virions [13] and during the fusion process [14, 15]. 
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Figure 3. Ribbon diagram of the TBE virus E protein dimer in top view (A) and side 
view (B). Each of the monomers is composed of three distinct domains, domain I (red), 
domain II (yellow), domain III (blue). The cd loop at the tip of domain II is highlighted in 
green. The positions of the carboxy terminal stem-anchor regions are indicated, and the first 
residue of the carbyhydrate (CHO) attached to Asn154 is shown [10].  
 
The cd loop structure at the tip of DII (Figure 3, indicated in green) plays a 
significant role in the fusion process. It is almost fully conserved among all 
flaviviruses. The cd loop functions as an internal fusion peptide during 
membrane fusion and is therefore also called fusion peptide loop (FP loop) [16]. 
At neutral pH, the fusion loop is buried in a hydrophobic pocket, which is 
formed by DI and DIII of the opposite subunit and an oligosaccharide attached  
 A. 
 B. 
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to DI. This shields the fusion loop from interactions with membranes in native 
configurations [10, 11, 13, 17]. The E protein also mediates receptor binding, in 
additionl to its function during the fusion process, which leads to the uptake of 
the virus into the host cell. [18-25]. To date, the crystal structure of the full 
length E protein is not known. 
 
1.2.2. Structural organization of flavivirus particles 
Cryo-electron microscopy (cryo-EM) and image reconstructions of mature 
DenV, YFV and WNV revealed an icosahedral, so-called herringbone 
organization of 180 E proteins, consisting of 30 rafts of three parallel E protein 
dimers (Figure 4). 
 
 
Figure 4. The mature flavivirus particle. Packing of the E proteins in the mature virus, 
showing the herringbone pattern. One of the 30 rafts, each containing three parallel dimers, is 
highlighted. Domains I, II, and III are colored red, yellow, and blue, respectively, with the 
fusion peptide in green. Symmetry axes are labeled 5 (fivefold), 3 (threefold) and 2 (twofold) 
respectively modified from [13]. 
 
This arrangement makes the viral membrane largely inaccessible from the viral 
exterior and DIII protrudes from the smooth viral surface. 
Structural data from cryo-EM reconstructions revealed also that the flavivirus E 
protein contains a double transmembrane anchor (Figure 5), exposing the  
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carboxy termini at the external surface of the membrane. The two amphipathic 
α-helices of the stem are oriented parallel to the viral membrane. Through their 
hydrophobic sides, they are half buried in the outer leaflet of the lipid bilayer 
(Figure 5) [26].  
 
 
 
 
Figure 5. Schematic diagram of the TBEV E protein homodimer containing stem and 
anchor regions. Illustration of the E protein homodimer of the mature virus particle, lying 
flat on the virus surface. The domains of the E protein homodimer are indicated in the colors 
red (Domain I), yellow (Domain II) and blue (Domain III). The double transmembrane anchor 
is indicated in green and the stem region, containing the two α-helices (Helix1 and Helix2), 
indicated in purple, are oriented parallel to the viral membrane and are half buried in the outer 
leaflet of the lipid bilayer (illustration modified, obtained from Stiasny, K.). 
 
Fusion Peptide Loop 
Double 
Transmembrane 
Anchor 
    Helix1  Helix2 
     Stem 
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1.2.3. Structure of the E protein post-fusion form 
Studies on flavivirus membrane fusion have shown that this process is triggered 
by a slightly acidic pH with a threshold around 6.6. This fact suggests that 
fusion of the viral with the host membrane can already occur in early 
endosomes. Such studies were done using cell-cell fusion or virus-liposome 
fusion assays with DenV, JEV, St. Louis encephalitis virus (SLEV), WNV, 
Murray Valley encephalitis virus (MVEV) and TBEV [27-37]. So far, detailed 
kinetic data have only been published for TBEV [37]. Experimental data 
demonstrated that, during the fusion process, exposure to acidic pH leads to a 
complete oligomeric rearrangement of the E proteins in the viral membrane. The 
dimeric pre-fusion form of the E protein converts to a trimeric post-fusion form 
[37]. This post-fusion form was shown to be significantly more thermostable 
than the E dimers (Figure 6A) [38]. Up to now, no structural data exist for the 
full-length E trimer but X-ray crystal structures are available for sE trimers 
(Figure 6B) [14], which were produced by trimerization at low pH values in the 
presence of liposomes [39]. 
 - 9 -
 
 
 
 
 
 
 
 
 
 
Figure 6. Surface representation of the crystal structure of the TBEV E protein dimer 
(A) and the E protein trimer (B). The domains of one monomer are highlighted, indicating 
domain I (red), domain II (yellow) and domain III (blue). The fusion peptide loop is colored 
in orange and can be seen to be covered in the pre-fusion, dimeric structure and to be exposed 
in the post-fusion trimeric structure. The crystallized glycoproteins lack the stem and anchor 
region [6, 10].  
 
The structural analyses revealed that the domains change their arrangement 
relative to each other but are not altered in their structural organization. This can 
be seen by comparison of a single monomer of the TBEV E protein in its native 
pre-fusion (Figure 7A) and post-fusion form (Figure 7B) [14]. 
 
  A.                                                                                       B. 
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Figure 7. Ribbon diagram (A-B) and schematic (C-D) of TBEV E proteins in their pre- 
and post-fusion conformations.  
(A-B) Curved arrows indicate the movements of DII (yellow arrow) and DIII (blue arrow) to 
reach their positions in the post-fusion conformation. The open star indicates the position of 
the last residue of the crystallized sE fragment [14].  
(C) Side view of the full-length E homodimer in its pre-fusion conformation. 
(D) Side view of the full-length E trimer in its post-fusion conformation. 
Color codes: DI, red; DII, yellow; DIII, blue; fusion peptide loop, orange; helices 1 and 2 in 
the stem indicated as H1 and H2; C-terminal transmembrane helices of the membrane anchor, 
indicated as TM1 and TM2 [4] 
  A.                                                                                              B. 
 C. 
 D. 
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The ribbon diagram (Figure 7) depicts the conformational switch, including a 
reorganization of the molecule. In the course of this reorganization the anti-
parallel dimer, oriented horizontally with respect to the viral membrane (Figure 
7C), switches into a perpendicularly oriented trimer (Figure 7D). In the trimeric, 
post-fusion conformation, the monomeric subunits are arranged in parallel. It is 
remarkable that the polypeptide chain and the structural integrity of the three 
domains remain largely unchanged. These transitions are only possible because 
of the hinge-like structures and the flexibility at the junctions between DI and 
DII and between DI and DIII. This flexibility is important to facilitate the 
reorientation of the domains relative to each other, which is the major change 
during the dimer-trimer conversion (Figure 7A-B). The position of DII relative 
to DI shows minimal differences in both forms. In contrast, DIII adopts a 
completely new position. It relocates from the end of the native E protein rod to 
the side of DI (Figure 7A-B). The interface of DI-DIII of the native E monomer 
possesses tight interactions, involving a number of van der Waals contacts, salt 
bridges and hydrogen bonds. These tight junctions must be broken to allow 
domain movement. It has been shown that the protonation of one of the 
conserved histidines (His323) at this interface is an essential driving force for 
this dissociation [9]. After the folding back of DIII, the E protein structure 
acquires a hairpin-like orientation. The position of the carboxy terminus of DIII 
indicates that the stem follows the grooves in the full-length post-fusion 
structure. The grooves are generated at the interface between the DIIs, leading to 
the juxtaposition of the membrane anchor and the membrane inserted FP loops, 
as schematically shown in figure 7D. 
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In modeling studies, helix 1 of the stem was fitted into the existing trimeric, 
post-fusion structure (Figure 8). It was shown that the best match for the “stem” 
region is obtained when conserved residues of helix 1 are directed toward the 
groove formed by the two DIIs [14] . 
 
      
Figure 8. Ribbon representation of the side view of the sE trimer with the modelled helix 
1 (H1) of the stem. The αA and αB helices of domain II are labeled. The modeled H1 helix is 
indicated in a semi-transparent purple ribbon, showing its path in between domain II. In this 
modeling study, it was postulated that the presence of H1 will force the tips of domain II to 
move apart (indicated by the gray arrows at either side of the sE trimer) [14]. Color codes: 
Domain I (red); Domain II (yellow); Domain III (blue). 
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1.3. The mechanism of flavivirus fusion  
The proposed membrane fusion mechanism of flavivirus is a multistep process. 
Most of the intermediate stages and structures are still only hypothetical and 
need further experimental confirmation (Figure 9A-D).  
 
           
Figure 9. Model of the flavivirus membrane fusion mechanism. (A) Metastable E dimer in 
mature virions. (B) Dissociation of the E dimers at acidic pH, outward projection of E 
monomers, and interaction of the FP with the target membrane. (C) Trimerization, DIII 
relocation, and “zippering action” of the stem. (D) Formation of the post-fusion trimer and 
opening of the fusion pore. Red, DI; yellow, DII; blue, DIII; orange, FP; purple, stem (linker 
between DIII and the transmembrane anchors); green, transmembrane anchors  
 
It was shown that the flavivirus membrane fusion initiates with the dissociation 
of the E dimers into monomers (Figure 9B) [36]. The E monomers are brought 
in a position which makes an interaction between target membrane and the 
fusion loops possible (Figure 9B). Trimerization of the E protein occurs by the 
relocation of DIII and it is believed that a “zippering action” of the stem brings 
the host cell and viral membranes in close proximity, which leads then to the 
formation of a lipid stalk ( hemifusion intermediate) (Figure 9C). In the last step 
the post-fusion trimer is formed leading to the opening of the fusion pore 
(Figure 9D) [4]. 
    A.                            B.                              C.                                      D. 
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1.4. Expression of recombinant flavivirus E proteins 
Different methods have been used for the expression of flavivirus proteins 
previously. 
1.4.1. Bacterial expression systems 
DenV envelope protein was expressed, using Escherichia coli (E.coli) as host 
cells [40]. With this expression system, it was possible to yield up to 2 mg of 
purified recombinant E protein from 1 liter bacterial culture. The achieved 
recombinant protein had a correct size of about 55kDa, but was non-
glycosylated. 
1.4.2. Mammalian expression systems 
Hela and Cos cell lines are mammalian cells, which were used for the expression 
of flavivirus particles and subviral particles [41-47]. 
1.4.3. Yeast expression systems 
Expression of recombinant flavivirus proteins in Pichia pastoris ( P.pastoris ) 
showed extensive proteolytic degradation of the recombinant E protein [40]. 
Expression of the WNV E protein was performed using the yeast two-hybrid 
system [48].  
1.4.4. Insect cell expression systems 
Recombinant JEV prM and E proteins were produced using Sf9 insect cells. The 
intracellular E protein was shown to be protective in mice against lethal JEV 
challenges [49, 50].  
Bac-to-Bac® TOPO® Expression System (Invitrogen Corporation, Carlsbad, 
CA) was used to generate a recombinant baculovirus, providing some 
advantages in the expression of recombinant proteins. This method reduces the 
need for multiple rounds of plaque purification as well as requiring less than two 
weeks to identify a recombinant baculovirus. The crystallization of the WNV sE 
protein was possible because of its successful expression in this system [51].  
Drosophila melanogaster Schneider (S2) cells have become increasingly 
utilized over the past few years for the expression of heterologous proteins. 
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Drosophila expression system (DES) was used to produce, for example, DenV E 
protein [11]. In this system, a simple plasmid vector for the expression of 
heterologous proteins, carrying a metallothionin (pMT) promoter for heavy 
metals inducible expression [52, 53], is the basic tool of this expression system. 
High levels of protein expression can be achieved by the co-transfection of the 
expression plasmid with a plasmid encoding resistance to blasticidin for 
selection. After three weeks of selection, a stable cell line is obtained that 
expresses the protein of interest. Proteins of prokaryotic, eukaryotic and viral 
origin expressed in this system were properly processed and biologically active 
[54-56]. Based on this evidence, DES has become a very effective gene 
expression system and it was selected in this work to express different truncated 
recombinant TBEV E proteins, including the stem region. 
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2. Objectives  
2.1. Definition and scientific question of the project 
The objective of this study was the expression, purification, and conversion into 
the trimeric postfusion form of two different truncated TBEV E proteins, (i) E 
protein missing helix 2 of the stem and the whole transmembrane anchor 
(TBEsE H1_dstrep) and (ii) E protein missing only the transmembrane anchor 
(TBEsE H1H2_dstrep).  
The trimeric post-fusion form of these proteins will then be used in additional 
studies to determine their X-ray crystal structure. 
Knowledge about the X-ray structure of these post-fusion forms of the flavivirus 
E protein will help with explaining the impact of the stem region during the 
membrane fusion process, thus contributing significantly to our understanding of 
the fusion mechanism. 
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3. Materials and Methods  
The chemicals and media which were used in this work were purchased from 
Sigma, Fluka, Qiagen, Promega, Invitrogen, Schneider and Lonza. Restriction 
enzymes were obtained from Fermentas.  
 
3.1. Manipulation of nucleic acids  
3.1.1. Buffers and oligonucleotides 
10x TBE buffer                            108g Tris/HCl  
                                                       55g Boric acid 
                                                      8.3g EDTA (Tritiplex III) 
                                                      Made up to 1 liter with ddH2O 
                                                      adjusted to pH 8.0   
 
DNA loading buffer                      30% (v/v) glycerol 
                                                    0.25% (w/v) bromphenol blue 
                                                    0.25% (w/v) xylene cyanol 
 
Table 1. List of primers. Primers were purchased from VBC Biotech (Austria). The 
respective primer for each construct contained the cleavage sites for Bsp120I (red) and BglII 
(blue). 
OLIGONUCLEOTIDE PRIMER  SEQUENCE  
Forward [3´- 5´] TTTAGATCTGCAACGGTGAGGAAAGAAAG
Reverse [5´- 3´] TBEsE H1 AAGGGCCCGTGCTCTCCTATCACTGTCA 
Reverse [5´- 3´] TBEsE H1H2 AAGGGCCCGATGCTGTTGAAAGCGCCAC 
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3.1.2. Polymerase chain reaction (PCR) 
The desired constructs were amplified using the method of Saiki [57]. For the 
reaction mixture, 10-50ng DNA (template) in 10µl water, 1µl each of a forward 
and a reverse specific primer (100µM), 16µl nucleotide mix (1.25mM dATP, 
dCTP, dGTP, dTTP), 10µl high fidelity buffer [10x] and 1µl Advantage high 
fidelity-2-polymerase (Clontech-Takara Europe, France) were mixed and filled 
up to a final volume of 100µl with water. The reactions were performed in a 
thermal cycler (PerkinElmer). 
 
3.1.3. Digestion and restriction enzymes 
Digestion of DNA was performed using enzymes purchased from Fermentas 
(Canada) according to the manufacturer´s protocols. For efficient digestion, 2-
10µg DNA as well as the appropriate volume of enzyme and buffer was 
incubated for 60 minutes at 37°C. 
 
3.1.4. Agarose gel electrophoresis 
Agarose gel electrophoresis was performed in a BioRad electrophoresis cell 
(BioRad Laboratories, Hercules, CA). A 1% (w/v) solution of agarose gel was 
prepared by dissolving the agarose (Serva GmbH, Heidelberg, Germany) in 
1xTBE buffer with Ethidium bromide to a final concentration of 0.0025mg/ml. 
The gel solution was poured into a casting form provided with a gel comb for 
polymerisation. 1xTBE buffer was used as an electrophoresis buffer. The DNA 
samples were mixed with 20% DNA loading buffer and pipetted into the wells 
formed by the comb in the gel. Electrophoresis was carried out for 20min at 
110V. The detection of the DNA fragments was done using a trans-illuminator 
(wavelength 302nm) combined with a camera for gel imaging. 
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3.1.5. DNA gel extraction and PCR-fragment purification 
The extraction of the DNA from the gel and PCR purification protocols were 
performed using the QIAquick gel extraction kit and QIAquick PCR purification 
kit (Qiagen, Valencia, CA), according to the manufacturer´s instructions. 
 
3.1.6. DNA ligation 
DNA fragments were ligated using T4 DNA ligase (30 Weiss U/µl, Fermentas, 
Canada). An insert:vector ratio of 19:1 was used to ensure high ligation 
efficiency. The ligation reaction was performed overnight at room temperature, 
according to the manufacturer´s protocol. After ligation, the proteins were 
removed using the PCR purification kit (Qiagen, Valencia, CA). 
 
3.1.7. DNA sequencing 
Sequencing was performed using fluorescence-labeled dideoxynucleotides as 
first described by Sanger [58]. The reaction was carried out with ABI Prism Big 
Dye Terminator Cycle Sequencing Kit. 0.5µg DNA was resuspended in 10µl 
water and mixed with 6µl specific primer (0.1M) and 4µl Big Dye Ready mix 
(containing nucleotides and polymerase). The reaction was performed in a 
thermal cycler (PerkinElmer) with the following settings: 20s, 96°C ?[ 25x 90s, 
96°C ? 15s, 50°C ? 4min, 60°C ? 4°C ∞] 
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3.2. Bacterial cultures 
3.2.1. Media and buffers 
LB medium                                  10g Bactotryptone 
                                                       5g Yeast extract 
                                                     10g NaCl,  
                                                      adjusted to pH 7.0  
                                                      made up to 1L with ddH2O  
                                                      autoclaved 
 
LB agar medium:                        LB medium 
                                                    20g/l Agar 
                                                    made up 1L with ddH2O 
                                                    autoclaved 
 
SOC Medium                             20g Bactotryptone 
                                                     5g Yeast extract 
                                                   0.5g NaCl  
                                                   made up 1L with ddH2O  
                                                   autoclaved,  
                                                   10ml of 1M MgCl2  
                                                   10ml of 1M MgSO4           added prior to use 
                                                   20ml of 1M Glucose 
                                                   sterile filtered 
 
Antibiotic stock soloution: 
Ampicillin                                   100mg/ml in ddH2O stock solution,  
                                                    sterile filtered 
                                                    final concentration: [100µg/ml] 
                                                    stored at -20°C 
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3.2.2. Bacterial strains: 
The following bacterial strain purchased from Invitrogen (Invitrogen 
Corporation, Carlsbad, CA) was used: 
Table 2. Bacterial strain for cloning. 
HOST  STRAIN GENOTYPE 
Escherichia coli DH5α  
chemically competent cells 
F-, φ 80Δ lacZΔM15Δ(lacZYA-
argF)U 169 deoR recA1 endA1 
hsdR17(rk-mk+) phoA supE44 thi-1 
gyrA96 relA1 
 
3.2.3. Transformation of chemically competent cells 
Chemically competent cells were thawed on ice, 20µl of ligation product was 
mixed with 50µl of the cells followed by incubation on ice for 20 minutes before 
heat shock at 42°C for 30 seconds and then placed on ice again for 2 minutes. 
1ml SOC medium was added and the cells were incubated for one hour at 37°C 
shaking at 225 rpm in an incubator. 100µl from the transformation mix were 
spread on LB agar plates, containing the appropriate antibiotic, and incubated at 
37°C overnight. 
 
3.2.4. Overnight culture 
A single colony, picked from a LB-agar plate was grown overnight in a shaking 
incubator at 37°C and 225 rpm in 5ml LB medium containing the appropriate 
antibiotic.  
 
3.2.5. Isolation of plasmid DNA from transformed E.coli 
The Plasmid Mini Kit (Qiagen, Valencia, CA) was used for DNA isolation to 
identify colonies containing the correct plasmid. The cells were harvested by 
centrifugation and purified by the alkaline lysis method following the 
manufacturer´s instructions. 
 - 22 -
3.3. Protein chemistry 
3.3.1. Materials and buffers 
2 x HEPES Buffered Saline         0.05M HEPES 
                                                     0.0015M Na2HPO4 
                                                     0.280M NaCl 
                                                     made up with ddH2O, 
                                                     adjusted to pH 7.1 
 
CaCl2                                           2M CaCl2 
                                                    made up with ddH2O,  
                                                    stored at -20°C 
 
 
Wash Buffer W                          0.10M Tris/HCl 
                                                   0.15M NaCl 
                                                   0.001M EDTA  
                                                   made up with ddH2O,  
                                                   adjusted to pH to 8.0 
 
Elution Buffer E                        0.10M Tris/HCl 
                                                   0.15M NaCl 
                                                   0.001M EDTA  
                                                   0.0025M Biotin 
                                                   made up with ddH2O 
                                                   adjusted pH to 8.0  
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Phosphate Buffered Saline       16.0g NaCl 
                                                    0.4g KCl 
                                                    0.4g KH2PO4 
                                                    5.8g Na2HPO4 x 12 H2O, 
                                                   made up with 2L ddH2O 
                                                   adjusted to pH to 7.4 
 
Carbonate Buffer                        1.59g Na2CO3 
                                                    2.59g NaHCO3 
                                                    made up with 0.5L ddH2O 
                                                   adjusted to pH to 9.6 
 
 
Laemmli sample buffer (LSB)   0.125M Tris pH 6.8  
                                                    2% SDS 
                                                   10% Glycerine,  
                                                   0.0025% Bromphenol blue 
                                                     5% β-Mercaptoethanol 
 
TAN-Buffer                                0.05M Triethanolamine 
                                                    0.10M NaCl  
                                                    made up with ddH2O 
                                                    adjusted pH to 8.0 
 
MES-Buffer                                0.05M 1-Morpholino Ethanesulfonic acid 
                                                    0.10M NaCl 
                                                    made up with ddH2O 
                                                    adjusted pH to 5.5 
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3.3.2. Protein purification 
Purification was performed with the Strep-tag technology using the 
chromatographic ÄKTA fast protein liquid chromatography (FPLC) system ( 
GE Healthcare, UK Limited). The cell culture supernatant was clarified by 
centrifugation (10,000 g, 45 minutes, 4°C) and frozen at -20°C. For purification, 
1.5 liters were thawed, centrifuged (10,000 g, 30 minutes, 4°C) and filtrated 
through a 0.22µm filter. After this procedure, the solution was concentrated by 
ultra filtration (Sartorius, Germany) according to the manufacturer´s protocol. 
The Strep-tag column was pre-washed and equilibrated by washing with buffer 
W, with twice the column volume. The supernatant was loaded onto the column 
(2ml/min). The column was washed with 25ml buffer W until a constant 
baseline was reached. The elution of the protein was performed with buffer E.  
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3.3.3. Denatured enzyme linked immunosorbent assay (ELISA)  
Nunc microtiterplates were coated at room temperature in a humid chamber with 
polyclonal guinea pig anti-TBEV-Immunglobulin (2.5µg/ml in carbonate buffer 
pH 9.6). The samples were denatured for 30 minutes with 0.4% SDS at 65°C. 
Further dilutions were carried out in PBS pH 7.4 + 2%Tween-20 + 2% filtered 
sheep serum filtered. Aliquots of 50µl of the diluted antigen were applied to the 
microtiterplates. After incubation for 2 hours at 37°C in a humid chamber, the 
plates were washed three times with PBS pH 7.4 + 0.05% Tween-20. 50µl of a 
TBEV-specific polyclonal rabbit antibody was added and after incubation in a 
humid chamber at 37°C, the plates were washed again three times with PBS pH 
7.4 + 0.05% Tween-20. For detection of the bound antibody, 50µl of a 
peroxidase conjugated anti-rabbit Ig (horseradish peroxidase linked whole 
antibody from donkey, GE Healthcare, UK Limited) was used. After an 
additional hour of incubation at 37°C in a humid chamber, the plates were 
washed with PBS pH 7.4 + 0.05%Tween-20. 50µl of ortho-Phenylendiamine 
(Sigma-Aldrich, St. Louis, USA) in phosphate-citrate buffer pH 5.0 (1mg/ml) + 
1µl/ml 30% H2O2 was used as a substrate. The developed colour was measured 
at 490nm extinction and the antigen concentration was determined using 
purified TBEsE H1 protein with a known protein concentration as standard. 
 
3.3.4. Protein precipitation with deoxycholic acid (DOC) –Tricholoroacetic 
acid (TCA) for SDS-PAGE 
Protein solutions were incubated with 0.015% DOC at room temperature for 10 
minutes and afterwards precipitated with 5% TCA for 30 minutes at 4°C, 
followed by centrifugation (4,000 g, 20 minutes, 4°C, Multifuge 4KR, Heraeus). 
The pellet was washed three times with ice cold acetone (4,000 g, 10 minutes, 
4°C) and dissolved in 20µl 1x sample buffer (LSB + β-mercaptoethanol). 
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3.3.5. SDS – Polyacrylamide gel electrophoresis with Coomassie staining 
[59] 
The electrophoresis was performed at 200V using 0.75mm thick gels with a 
15% separating gel and a 5% stacking gel. 
Stacking Gel (5%)          40% Acrylamide-Bisacrylamide (37.5:1)  0.630ml 
                                        1M Tris pH 6.8                                         0.630ml 
                                        ddH2O                                                       3.660ml 
                                        10% SDS                                                   0.050ml 
                                        TEMED                                                     0.005ml 
                                        10% Ammonium persulfate (APS)            0.025ml 
 
Separating Gel (15%)     40% Acrylamide-Bisacrylamide (37.5:1)  3.75ml 
                                        1M Tris pH 6.8                                          2.50ml 
                                        ddH2O                                                        3.59ml 
                                        10% SDS                                                   0.10ml 
                                        TEMED                                                     0.01ml 
                                        10% Ammonium persulfate (APS)            0.05ml 
 
Buffer for Electrodes             288g Glycine 
                                                 60g Tris 
                                                made up with 2L ddH2O (= 5 x buffer) 
                                                shortly before use 0.1% SDS was added 
 
Fixating Solution : 50% (v/v) ethanol in water with 10%(v/v) acetic acid                     
                                                Ethanol 95% (v/v)                          500ml 
                                                Acetic Acid                                     100ml 
                                    made up with water to a final volume of  1000ml 
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Coomassie staining solution:  
                                                 0.1% (w/v) Coomassie blue R350 
                                                  20% (v/v)  Methanol 
                                                  10% (v/v)  Acetic Acid 
 
Destaining solution:  
                                                  50% (v/v) Methanol 
                                                  10% (v/v) Acetic Acid 
 
For Coomassie staining, the gel was first shaken in a fixing solution for 30 
minutes at room temperature. Staining with the Coomassie solution was 
performed by shaking at room temperature for a further 30 minutes. The 
destaining was performed with the destaining solution, by shaking the gel at 
room temperature and changing the solution three times every 10 minutes. 
Finally the gel was destained overnight at room temperature by shaking in 
destaining solution. After destaining, the gel was dried for 2 hours, using a gel 
dryer (Model 543, BioRad) according to the manufacturer´s manual. 
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3.3.6. Liposomes 
 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine, 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphoethanolamine (Avanti Polar Lipids, Inc., Birmingham,Ala.) 
and 1-cholesterol (Sigma) were mixed in a molar ratio of 1:1:1 from stock 
solutions in chloroform. The mixture was dried to a thin film with a rotary 
evaporator and then dried further under high vacuum for at least 2 h. The lipid 
film was hydrated in 10 mM triethanolamine (pH 8.0)–140 mM NaCl and 
subjected to 5 cycles of freeze-thawing, followed by 21 cycles of extrusion 
through two 200-nm pore size polycarbonate membranes with a Liposofast 
syringe-type extruder (Avestin, Ottawa, Canada). 
 
3.3.7. Low pH treatment of E proteins 
10µg of the purified proteins at a concentration of 100 µg/ml in buffer E 
(100mM Tris/HCl, 150mM NaCl, 1mM EDTA, 5mM Desthiobiotin, pH 8.0) 
were mixed with liposomes in a ratio of 1 µg of E protein to 15 nmol of lipid 
and incubated for 5 min at 37°C. The samples were acidified using a buffer 
consisting of 0.35 M morpholineethanesulfonic acid (MES), which had been 
pre-titrated to yield the desired final pH of 5.4 when the sample was added. The 
mixture was incubated for 30 min at 37°C.  
As a control, TBEV [10µg E protein] at a concentration of 100µg E/ml were 
incubated with 40µl 350mM MES for 10 min at 37°C.  
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3.3.8. Sedimentation analysis 
Sucrose gradient 7%               7 g Sucrose (w/w) 
                                                1ml 10% TX-100 
                                                made up to 0.1L with 100 ml TAN pH 8.0 (w/w) 
 
 
Sucrose gradient 20%            20 g Sucrose (w/) 
                                               1ml10% TX-100 
                                               made up to 0.1L with 100 ml TAN pH 8.0 (w/w) 
 
 
To analyze the oligomeric structure of the expressed proteins, the samples were 
adjusted to a Triton X-100 final concentration of 1%, incubated for 1 h at 37°C 
and then applied to 7 to 20% (wt/wt) continuous sucrose gradient in TAN buffer 
(pH 8.0) containing 0.1% Triton X-100. As controls, TBEVpH 8.0 and low pH 
treated TBE virus were used. The centrifugation was carried out for 20 h at 
38,000 rpm at 15°C in a Beckman SW40 rotor and fractions of 600µl were 
collected by upward displacement with an ISCO model 640 fraction collector. 
The amount of E protein in each fraction was determined by a quantitative four-
layer ELISA after denaturation of the samples with 0.4% SDS as described 
above. 
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3.4. Expression of TBEsE H1_dstrep and TBEsE H1/H2_dstrep in 
Drosophila cells 
3.4.1. Vectors and plasmids 
For the recombinant expression of TBEsE H1_dstrep and TBEsE H1/H2_dstrep, 
the expression plasmid pT350 and the selection vector pCoBlast, both described 
in table 3, were used. 
Table 3. Vector systems for protein expression. 
VECTOR PROPERTIES 
plasmid pT350 
provided by the Institut Pasteur  
(France) 
Modified plasmid for inducible 
expression of recombinant protein 
from the metallothionein (pMT) 
promotor [52, 53]. 
Cloning Sites:  
BglII       3´- AGATCT – 5´ 
Bsp120I  3´- CCCGGG – 5´ 
Bip-Export Sequence 
Enterokinase Cleavage Site 
Double Strep Tag 
Stop 3´ - AGT – 5´ 
pCoBlast Vector 
purchased from Invitrogen 
Selection vector, lyophilised in TE 
pH8.0 
For selection with blasticidin 
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3.4.2. Initiation of a cell culture from a frozen stock 
S2 cells (1x107cells) from a frozen stock were quickly thawed at 30°C. The 
outside of the vial was decontaminated with 70% ethanol and the cells were 
transferred into a 25cm2 cell culture flask with 5ml of room temperature 
Schneiders complete Drosophila medium (Invitrogen Corporation, Carlsbad, 
CA) containing 10% foetal bovine serum (Invitrogen Corporation, Carlsbad, 
CA) (FBS, thawed and inactivated before use at 65°C for 30 minutes) and 1% 
Penicillin Streptomycin Antimycoticum (PSA, Invitrogen Corporation, 
Carlsbad, CA). The cells in the flask were incubated at 28°C for 30 minutes 
followed by resuspension the cells and centrifugation at 1,000 g for 7 minutes at 
room temperature. The medium was decanted and the cells were plated in 5ml 
fresh Schneiders complete Drosophila medium. The cells were incubated again 
at 28°C until they reached a density of 6 to 20 x 106 cells/ml. 
 
3.4.3. Measuring the cell density 
Cell densities were determined using a Casey cell counter (1TT, Schärfe 
System) according to the manufacturer´s protocol. 
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3.4.4. Transfection of S2 cells 
S2 cells were prepared for transfection by seeding 1x 106cells/ml in a 35 mm 
petri-disk in 3 ml Schneiders complete Drosophila medium. The cells were 
grown for 16 hours at 28 °C until they reached a density of 2 to 4x106cells/ml. 
The transfection mix (for each 35 mm petri-disk), (solution A) was prepared in 
microcentrifuge tubes with the following components: 36µl 2M CaCl2, 19µg 
recombinant DNA, 1µg selection vector. Sterile water was used to fill up the 
mixture to a final volume of 300µl. In a second microcentrifuge tube, 300µl 2x 
HEPES-buffered saline (solution B) was added. Solution A was then added drop 
wise to solution B under continuous vortexing. The resulting solution was 
incubated at room temperature for 40 minutes. During the incubation time, a fine 
precipitate formed and the solution was then added drop-wise to the cells under 
continous shaking of the cultures. The transfected cultures were incubated for 24 
hours at 28°C, then the Calcium phosphate solution was removed and the cells 
were washed twice with complete medium. Fresh Schneiders complete 
Drosophila medium was added and the cells were replated in a new well. After 
incubation for 24 hours at 28°C, the cell medium was removed and the cells 
were washed. Medium for selection was prepared by adding blasticidin in a final 
concentration of 25µg/ml to complete Schneiders complete Drosophila medium. 
The washed cells were resuspended in the new medium containing blasticidin in 
a final concentration of 25µg/ml. This selection medium was replaced every 3 
days until resistant cells started growing. 
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3.4.5. Amplification of stable transfected cells 
After 3 weeks of selection, stable transfected cells were established and the 
amplification of the cell culture was started. For this purpose the stable 
transfected cells were centrifuged at 1,000 g for 7 minutes, followed by 
decanting of the supernatant and resuspension of the cells in Schneiders 
complete Drosophila medium containing blasticidin. The cells were passaged at 
a 1:2 to 1:5 dilution after reaching a density of 6 to 20 x 107 cells/ml.  
 
3.4.6. Test of expression 
The stably transfected cells with a density of 1x106cells/ml were passaged in 
5ml Schneiders complete Drosophila medium. Protein expression was induced 
by adding copper sulfate to a final concentration of 0.5M. The cell cultures were 
incubated at 28°C. After 5 days of incubation, cells were centrifuged at 1000 g 
for 7 minutes and the supernatant was then used to test the expression of the 
recombinant protein using ELISA. 
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3.4.7. Preparation of frozen stocks 
Cryovials were labeled and placed on ice. Freezing medium was prepared, 
containing 75% Schneiders complete Drosophila medium, 10% heat-inactivated 
FBS, 5% PSA and 10% DMSO.The cells were pelleted by centrifugation at 
1000 x g for 7 minutes and resuspended in freezing medium at a density of 1 x 
107 cells/ml. The cell suspension was divided into 1ml aliquots per vial and put 
on ice at 4°C for 30 minutes. Then the vials were placed into a special storage 
unit at -80°C, which provided a slow freezing process of the cells. After 24 
hours, they were transferred into liquid nitrogen for long term storage. 
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4. Results  
4.1. Generation of recombinant plasmids for the expression of the 
recombinant TBEsE H1_dstrep and TBE sE H1/H2_dstrep proteins 
Two different expression plasmids – pT350-TBEsE H1 and pT350-TBEsE 
H1/H2 - for the recombinant expression in S2 cells of the corresponding proteins 
were generated. For this purpose, the cDNAs, designated TBEsE H1, and 
TBEsE H1/H2 were amplified by polymerase chain reaction (PCR) from the 
wild-type plasmid SV-Pwt [60]. This plasmid codes for the cDNA of the prM 
and E genes of TBE virus strain, Neudoerfl (GenBank accession no. U27495). 
PCR was performed using specific primers (Table 1, Materials & Methods). The 
cDNA named TBEsE H1 codes for the TBEV prM protein and the E protein 
including helix 1 of the stem (amino acids 1-428) (Figure 10A). The cDNA 
TBEsE H1/H2 codes for the TBEV prM protein and the E protein including the 
whole stem (helix 1 and helix 2) (amino acids 1-450), (schematically shown in 
Figure 10B).  
 
 
 
 
                                   
 
Figure 10. Schematic representation of the TBEV cDNA constructs TBEsE H1 (A), 
TBEsE H1/H2 (B) and TBE full length E (C). (A) TBEV cDNA coding for the prM protein, 
sE protein, and helix 1 of the E protein stem named TBEsE H1.(B) TBEV cDNA coding for 
the prM protein, sE protein and helix 1 and helix 2 of the E protein stem, named TBEsE 
H1/H2. (C) TBE full length E 
 
                A. 
 
                B. 
 
                C. 
 
 
     C      prM                     sE                        H1                H2             non structural proteins 
              prM                      sE                       H1                 
              prM                     sE                        H1               H2             
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After amplification of the cDNAs (TBEsE H1 and TBEsE H1/H2), they were 
separated by preparative agarose gel electrophoresis. The amplified cDNA 
molecules showed the expected size of about 2kbp (Figure 11).  
 
 
 
                 
Figure 11. Agarose gel electrophoresis of PCR amplified cDNAs TBEsE H1 and TBEsE 
H1/H2.Amplified double stranded cDNAs, coding for TBEsE H1 and TBEsE H1/H2 were 
separated according to their molecular weight by a 1% agarose gel. Lanes 1 and 2 show the 
PCR fragments of TBEsE H1 and lanes 4 and 5 the PCR fragments of TBEsE H1/H2. Both 
fragments showed the expected size of around 2kbp (indicated by the black arrow). Size 
marker (M): Lambda DNA-HindIII Digest (Fermentas, Canada). 
 
The PCR fragments were excised out of the agarose gel, and cloned into the 
expression vector pT350 (Figure 12), kindly provided by F. Rey, Institut Pasteur. 
This vector allows the expression of the protein of interest in Drosophila 
melanogaster Schneider 2 cells (Invitrogen Corporation, Carlsbad, CA, 
Cat.No:R690-07) under the control of a metallothionein promoter. In this system, 
the protein is expressed as a fusion protein, with an N-terminal Bip-Export 
Sequence (BipSS) and a C–terminal double Strep-tag (Figure 12). BipSS is 
essential for the export of the recombinant protein out of the cell into the cell 
culture supernatant and is cleaved by cellular proteases during export. The double 
Strep-tag can be used for purification and due to the presence of an enterokinase 
cleavage site (Figure 12), it can be cleaved off in vitro with enterokinase (EK). 
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Figure 12. Schematic representation of the plasmid pT350, used for the expression of 
TBEsE H1_dstrep and TBEsE H1/H2_dstrep. The recombinant plasmids pT350-TBEsE 
H1 and pT350-TBEsE H1/H2 were generated by cloning the cDNA sequence of TBEsE H1 
and TBEsE H1/H2 into the multiple cloning site of the vector pT350 after enzymatic 
digestion. The expression of the recombinant proteins is under the control of a metallothionin 
promoter (pMT). The vector contains a Bip-signal sequence (Bip SS), which mediates the 
export of the recombinant protein out of the cell, a double Strep-tag (green) for protein 
purification, an enterokinase cleavage site (orange) - to cleave the tag after purification of the 
protein - and a stop sequence (termination). 
 
The PCR fragments of TBEsE H1 and TBEsE H1/H2 and the expression vector 
pT350 were digested by a double digestion reaction with the restriction 
enzymes, BglII and BspI120. To avoid religation of the restricted plasmid, a 
dephosphorylation reaction was performed (see Materials&Methods). The 
cleaved inserts and the linearized vector were separated by agarose gel 
electrophoresis. The fragments of TBEsE H1 and TBEsE H1/H2 showed the 
expected size of about 2kbp. The digested fragments and plasmid were purified 
by Qiaex II Gel Extraction Kit (Qiagen, Valencia, CA). The amount of cDNA 
was estimated by analytical agarose gels (Figure 13).  
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Figure 13. Analytical agarose gel electrophoresis of the inserts TBEsE H1 (lane 1) and 
TBEsE H1/H2 (lane 2) and the linearized expression vector pT 350 (lane 3). Size marker 
(M): Lambda DNA-HindIII Digest (Fermentas, Canada). 
 
 
Recombinant plasmids pT350-TBEsE H1 and pT350-TBEsE H1/H2 were 
generated by performing a ligation reaction ( see Material&Methods) using 1:10 
molar ratios of the respective fragment and the linearized vector. The ligation 
mixtures were used to transform the chemically competent Escherichia coli 
(E.coli) strain DH5α (Invitrogen Corporation, Carlsbad, CA). After 
transformation, plasmid DNA was isolated from small scale plasmid 
preparations of a 4ml overnight culture from colonies. The correct DNA 
sequence was verified by sequence analysis (see Materials&Methods). A 
retransformation of E.coli DH5α (Invitrogen Corporation, Carlsbad, CA) with 
the correct, isolated, recombinant plasmid DNA was performed, followed by an 
additional large scale plasmid preparation. The correct sequences of both 
recombinant plasmids were again verified by sequence analysis (see 
Materials&Methods). 
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4.2. Expression of the recombinant proteins TBEsE Helix1_dstrep and 
TBEsE H1/H2_dstrep in Drosophila melanogaster - (S2) – cells 
4.2.1. Transfection 
Drosophila melanogaster (Schneider, S2) were transfected with the recombinant 
plasmids pT350-TBEsE H1 and pT350-TBEsE H1/H2 together with a 
blasticidin resistance selection vector (pCoBlast) (see Materials&Methods). 
Briefly, for transfection, S2 cells [3x106cells/ml] were seeded into 6 well plates 
and grown for 20 hours at 28°C. After transfection, the cell cultures were first 
incubated at 28°C for 24 hours in complete medium and then further grown in 
the presence of blasticidin for the selection of resistant cells, as described in 
Materials&Methods. Within the three week selection period, the cells were 
further propagated at 28°C, by continuously changing the cell culture medium 
containing blasticidin at the appropriate concentration of 25µg/ml. Protein 
expression was induced by the addition of copper sulphate to 5 ml cultures of 
stable transfected cells. The induced cell cultures were then incubated for 5 days 
at 28°C. After this period, the cells expressed the recombinant proteins and 
secreted them into the cell culture supernatant which was tested by measuring 
the E protein concentration. Aliquots of the supernatants were taken and a 
quantitative ELISA was performed (see Materials&Methods). The results of 
quantitative ELISA obtained with the cell culture supernatants from the 
transfections are displayed in tables 4 and 5. The expression levels ranged 
between 0.0 – 1.86µg/ml for TBEsE H1_dstrep and 0.0 – 0.82 µg/ml for TBEsE 
H1/H2_dstrep. 
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Table 4. Concentration of the TBE E protein in the supernatants of S2 cells transfected 
with pT350-TBEsE H1_dstrep.  
 
Sample Number E Protein 
Concentration [µg/ml]
1 0.027 
2 0.000 
3 0.171 
4 0.200 
5 0.950 
6 0.437 
7 1.860 
 
Table 5. Concentration of the TBE E protein in the supernatants of S2 cells transfected 
with pT350-TBEsE H1/H2_dstrep.  
 
Sample Number E Protein 
Concentration [µg/ml]
8 0.000 
9 0.543 
10 0.018 
11 0.823 
12 0.000 
13 0.321 
14 0.179 
 
The cultures that expressed the highest amount of recombinant TBEsE 
H1_dstrep (Table 4, No.7) and TBEsE H1/H2_dstrep (Table 5, No.11) were 
later used for large scale cultures (up to five liters). During this amplification 
process, regular aliquots were taken and frozen in liquid nitrogen for long term 
storage (see Materials&Methods).  
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4.2.3. Upscaling of protein expression 
For the production of larger quantities of recombinant proteins, an upscaling of 
cell culture conditions was requested. Transfected Drosophila cells can grow to 
high cell densities in cell cultures under shaking conditions. With the complete 
cell culture medium, containing fetal bovine serum (FBS), cells are more likely to 
clot under shaking conditions which would decrease cell viability. Therefore, the 
stable transfected cells were adapted to serum-free medium, according to the 
manufacturer´s instructions (see Materials&Methods). After adaption to serum-
free medium, containing blasticidin [12.5µg/ml], the cells were transferred to 
shaking conditions at 28°C and 120rpm (see Materials&Methods). Further 
upscaling was achieved by the using a bioreactor (WAVE, GE Healthcare, UK 
Limited). This system allows cells to be cultured up to a volume of five liters. 
The bioreactor was filled with cells diluted to a final density of 1.5x106 cells/ml 
in five liters of medium. When the cells were growing exponentially, protein 
expression was induced with 0.5M copper sulfate. Samples were taken at 
different intervals and E protein concentrations were determined by a quantitative 
SDS-ELISA (see Materials&Methods). The resultant E protein concentrations for 
TBEsE H1_dstrep are displayed in table 6 and for TBEsE H1/H2_dstrep are 
displayed in table 7. 
 
Table 6. Concentration of the TBE E protein in the supernatants of S2 cells transfected 
with pT350-TBEsE H1_dstrep in the bioreactor. 
 
Days post-induction TBEsE H1_dstrep [µg/ml] 
0 0 
2 0,312 
4 1,021 
7 1,521 
8 1,576 
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Table 7. Concentration of the TBE E protein in the supernatants of S2 cells transfected 
with pT350-TBEsE H1/H2_dstrep in the bioreactor. 
 
Days post-induction TBEsE H1/H2_dstrep [µg/ml] 
0 0 
2 0,350 
6 1,750 
7 2,973 
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4.2.4. Purification of the recombinant proteins from cell culture 
supernatants  
The cell culture supernatant was concentrated by ultra filtration using the 
concentrator Viva-flow (Sartorious AG, Germany). Typically, 1500ml were 
concentrated to a final volume of 100ml, which corresponds to a 15-fold 
concentration. After this step, the recombinant protein was loaded onto a 5 ml 
Strep-tactin Superflow cartridge H-PR (IBA, Germany) using the 
chromatographic ÄKTA FPLC system (GE Healthcare, UK Limited) (see 
Materials&Methods). After a washing step, the sample was eluted with 0.025M 
desthiobiotin (Figure 14). 
 
 
Figure 14. Chromatogram of purification of TBEsE H1_dstrep. The ultra filtrated 
supernatant containing TBEsE H1_dstrep was purified using a Strep-tactin Superflow 
cartridge H-PR in combination with the chromatographic ÄKTA FPLC system. The sample 
was eluted from the column with 0.025M desthiobiotin, as specified by the elution peak (red 
arrow) in the fractions A3 to A7.  
 
The E protein concentrations during the production process of TBEsE H1_dstrep 
and TBEsE H1/H2_dstrep, including concentration and purification, were 
determined by SDS-ELISA (see Materials&Methods). The E protein 
concentrations were calculated as a percentage of the total initial protein  
Elution Peak 
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amount. The results obtained with TBEsE H1_dstrep are displayed in the 
diagram figure 15. A loss of about 60% E protein was detected after the ultra 
filtration step. During further purification steps, almost no additional loss of 
recombinant TBEsE H1_dstrep occurred (Figure 15, lane 10). 
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Figure 15. Recovery of E protein during the main steps of purification of TBEsE 
H1_dstrep. 1. Supernatant before clarification, 2. clarified supernatant, 3. supernatant after 
ultra filtration, 4. flow through of the purification column, 5. wash of the purification column, 
6. pooled peak fractions (A3 to A7, Figure 14).  
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The results obtained with TBEsE H1/H2_dstrep are displayed in figure 16, in 
this case no detectable loss of protein was observed during the ultra filtration 
step. However, due to suboptimal binding of the protein to the affinity strep-
tactin column, the recovery of purified product was maximal only about 20%.  
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Figure 16. Recovery of E protein during the main steps of purification of TBEsE 
H1/H2_dstrep. 1. Supernatant before clarification, 2. clarified supernatant, 3. supernatant 
after ultra filtration, 4. flow through of the purification column, 5. wash of the purification 
column, 6.pooled peak fractions. 
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4.2.5. Determination of the purity of the recombinant TBEsE H1_strep 
The purity of the purified recombinant TBEsE H1_dstrep protein was 
densitometrically determined after separation of the sample by SDS-PAGE. For 
this process, an aliquot of the purified recombinant protein was precipitated by 
DOC-TCA, subjected to SDS-PAGE and stained with Coomassie Brilliant Blue 
(see Materials&Methods). The protein of approximately 52kDa was typically 
calculated to be between 70-95% pure (Figure 17). 
 
 
                                                 
Figure 17. SDS-PAGE of the recombinant TBEsE H1_dstrep. M: Molecular weight 
marker in kDa, lane 1: clarified cell culture supernatant, lane 2: purified TBEsE H1_dstrep 
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4.2.6. Determination of the oligomeric state of TBEsE H1_dstrep  
In order to determine the oligomeric state of the expressed TBEsE H1_dstrep 
proteins at different stages of the purification process, aliquots of TBEsE 
H1_dstrep protein from (i) the S2 cell culture supernatant, (ii) after elution from 
the Strep-tactin Superflow cartridge H-PR, and (iii) after low pH treatment in 
the presence of liposomes with 1% Trition X-100 were used for sedimentation 
analysis (see Materials & Methods). As can be seen in figure 18, the vast 
majority of the TBEsE H1_dstrep proteins were in a dimeric arrangement 
directly after expression. After purification with a Strep-tactin column, the 
predominate form of the TBEsE H1_dstrep proteins was still a dimer. As 
expected, after low pH treatment in the presence of liposomes, the oligomeric 
state changed to a trimer, although only with a transition efficiency of about 
55%. 45% of the TBEsE H1_dstrep proteins remained in the dimeric 
conformation. 
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Figure 18. Sedimentation analysis of TBEsE H1_dstrep protein in the presence of 
deteregent. TBEsE H1_dstrep from the S2 cell culture supernatant (TBEsE H1_dstrep CC-
SN, red), TBEsE H1_dstrep after the Strep-tactin purification (TBEsE H1_dstrep purif., 
turquoise) and TBEsE H1_dstrep after Strep-tactin purification and low pH treatment (TBEsE 
H1_dstrep acid., blue), were solubilised with 1% Triton X-100, and centrifuged into 7 to 20% 
sucrose gradients (containing 0.1% Triton X-100) at pH 8.0. As controls, TBEV was 
incubated at pH 5.4 for 10 min (TBEV sol._ pH 5.4, black), or at pH 8.0 (TBEV sol._pH 8.0, 
black dotted line), solubilized, and analyzed as described above. The sedimentation direction 
is from left to right, and the positions of dimers (D) and trimers (T) are indicated. 
     80 
    100 
 %  40 
      20 
 - 49 -
5. Discussion 
In recent years, structural determinations of the fusion protein E in its pre- and 
post-fusion conformations have rapidly advanced our understanding of the 
flavivirus fusion mechanism [4, 10-15, 36]. Although only truncated forms of E, 
lacking the so-called stem-anchor region, were used for these studies, the 
knowledge of these structures led to a mechanical type model of the flavivirus 
fusion process (Figure 9) [4]. This suggested process involves a conformational 
switch from the pre-fusion dimer to the post-fusion trimer and thus a transition 
of the E molecule from an antiparallel dimer that is oriented horizontally with 
respect to the viral membrane into a parallel trimer, oriented perpendicular to the 
membrane. During this process, it is believed that the viral and cellular 
membranes are brought into close proximity, which is a prerequisite for the 
membrane fusion, by a so-called “zippering action”. For this mechanism, it was 
assumed that the stem follows the grooves, generated at the interfaces between 
the DIIs in the post-fusion trimer, which leads to the juxtaposition of the E 
membrane anchors and the insertion of the FP loops into the cellular membrane 
[4]. This mechanism had been confirmed by modelling studies which have 
shown that the best fit was obtained when conserved residues of the helix 1 of 
the stem were directed towards the DII of the same E monomer in the post-
fusion trimer [14]. The model of the flavivirus fusion process still needs further 
experimental conformation as the roles of the flavivirus stem region and most of 
the intermediate stages and structures are hypothetical. For these reasons, we 
conducted a study to generate a system for the recombinant expression of the 
TBEV E protein, including parts of or the whole stem region without the 
membrane anchor region, which could be used for further structural 
determination studies. Important for subsequent crystallization studies with the 
recombinant E protein are: the folding of the protein (including the formation of 
the disulfide bridges), achievable expression levels and adequate culture sizes. 
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Previous studies have shown that protein expression with Drosophila 
melanogaster cell lines, derived from primary culture of late stage embryos [61], 
was successfully used for the expression and crystallization of pre- and post-
fusion forms of several flavivirus E proteins [11-13, 15].  
The Drosophila expression system (Invitrogen Corporation, Carlsbad, CA) used 
in this study is a two-vector based expression system. One vector codes for 
blasticidin resistance, which is the selection marker, while the other codes for 
the protein of interest. Generation of stable, transfected cells expressing the 
protein of interest requires the simultaneous transfection of the cells with both 
plasmids. A major disadvantage of this system and its selection strategy is that 
cells, which were transfected only with the selection plasmid, are resistant to the 
selection but do not provide any expression of the protein of interest. Such cells 
can cause problems especially during long-term expression, for example by 
overgrowing expression-positive cells. Another drawback of such a two-vector 
based system is that if different cell cultures are transfected with the same 
construct in parallel, the transfection rate and therefore the resulting expression 
levels can vary massively - ranging in our case from no expression up to 
1.86µg/ml for TBEsE H1_dstrep (Table 4) and from no expression up to 
0.82µg/ml for TBEsE H1/H2_dstrep (Table 5). Monitoring the transfection 
efficiency of the cells with the expression plasmid is possible with 
immunofluorescence or a fluorescence- activated cell sorting (FACS) assay, 
however during the time period of this work, no established assay was available. 
A possible way to overcome the suboptimal conditions of the expression system 
would be the generation of a one-vector based expression system in which the 
selection marker, as well as the protein of interest, are encoded on the same 
plasmid. This would guarantee that the selected cells are also expressing the 
protein of interest, but it is not clear if such a selection-expression plasmid can 
be stable inserted into the Drosophila genome. The recombinant E protein 
wasexpressed as a TBEV prME pre-protein to ensure proper folding, as 
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previously described [12, 62]. This pre-protein was then processed by cellular 
proteases during the secretion pathway and expressed with an N-terminal 
secretion signal. This signal is an 18 amino acids long secretion signal of the 
Drosophila BiP protein (BiPSS, Figure 12), which is an immunoglobulin 
binding chaperone protein [63]. Both the prM protein as well as the BipSS are 
cleaved off by cellular proteases in the exocytotic pathway, leading to secretion 
of E protein into the cell culture medium. This allows one-step affinity 
purification via the C-terminal double Strep-tag directly from the concentrated 
cell culture supernatant. It transpired that the double Strep-tag is an optimal tag 
for the purification of proteins expressed in S2 cells, because (i) of its 
insensibility to Cu2+ ions, which were used for the induction of the expression, 
and (ii) of the particular suitability of the double tag for the binding of proteins 
expressed as oligomers. An enterokinase cleavage site for a possible elimination 
of the tag after purification was inserted, to prevent influences of the tag on the 
formation of the E trimer and especially of the incorporation of the stem region 
into the groove formed by the DIIs of the E protein. Sedimentation analyses 
have shown that only about 55% of the TBEsE H1_dstrep proteins, which were 
expressed as dimers, could be converted by low pH in the presence of liposomes 
into trimers, which represents a very low transition rate, compared to TBEsE, 
where 82% of the dimer proteins could be rearranged into trimers [37]. This 
result was quite surprising as the addition of the helix 1 of the stem was 
expected to increase the stability of the resulting trimer, compared to the sE 
trimers. Steric clashes during the transition process from dimer to trimer, caused 
by the double Strep-tags, are possible explanations for this result. During this 
work, no trimerization experiments in the absence of C-terminal tags were 
performed to verify this speculation. In the case of TBEsE H1/H2_dstrep, it was 
not possible to bind the protein onto the Strep-tactin column (Figure 16). This 
result could be explained by steric hindrances which prevent binding of the tag 
onto the column. 
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Another explanation can be that the tag was probably cleaved off during the 
expression, even without the addition of enterokinases. Unfortunately it was not 
possible to verify this phenomenon. Possible alternative purification strategies 
for the TBEsE H1/H2_dstrep proteins could be ion-exchange chromatography or 
affinity purification via monoclonal antibodies. 
In conclusion, it was possible to express correctly folded TBEsE H1_dstrep and 
TBEsE H1/H2_dstrep proteins in Drosophila S2 cells at high expression rates. 
We were able to establish a purification strategy for TBEsE H1_dstrep trimers 
which were produced in amounts sufficient for structural determination studies. 
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